Clinical Trial Update: Study of Tenofovir Alafenamide in HBV-Infected Pregnant Women [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating Tenofovir alafenamide in pregnant women with chronic hepatitis B and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Vemlidy (tenofovir alafenamide)

Snippet

Sponsor: First People's Hospital of Hangzhou | Conditions: Chronic Hepatitis b, Tenofovir Alafenamide Fumarate | Phase 4 | Status: RECRUITING